BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16912206)

  • 1. The shaping of a polyvalent and highly individual T-cell repertoire in the bone marrow of breast cancer patients.
    Sommerfeldt N; Schütz F; Sohn C; Förster J; Schirrmacher V; Beckhove P
    Cancer Res; 2006 Aug; 66(16):8258-65. PubMed ID: 16912206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
    Rentzsch C; Kayser S; Stumm S; Watermann I; Walter S; Stevanoviç S; Wallwiener D; Gückel B
    Clin Cancer Res; 2003 Oct; 9(12):4376-86. PubMed ID: 14555509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow.
    Feuerer M; Beckhove P; Bai L; Solomayer EF; Bastert G; Diel IJ; Pedain C; Oberniedermayr M; Schirrmacher V; Umansky V
    Nat Med; 2001 Apr; 7(4):452-8. PubMed ID: 11283672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammaglobin-A is a tumor-associated antigen in human breast carcinoma.
    Tanaka Y; Amos KD; Fleming TP; Eberlein TJ; Goedegebuure PS
    Surgery; 2003 Jan; 133(1):74-80. PubMed ID: 12563241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequencies of functional tumor-reactive T cells in bone marrow and blood of pancreatic cancer patients.
    Schmitz-Winnenthal FH; Volk C; Z'graggen K; Galindo L; Nummer D; Ziouta Y; Bucur M; Weitz J; Schirrmacher V; Büchler MW; Beckhove P
    Cancer Res; 2005 Nov; 65(21):10079-87. PubMed ID: 16267034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative and cytokine responses to class II HER-2/neu-associated peptides in breast cancer patients.
    Tuttle TM; Anderson BW; Thompson WE; Lee JE; Sahin A; Smith TL; Grabstein KH; Wharton JT; Ioannides CG; Murray JL
    Clin Cancer Res; 1998 Aug; 4(8):2015-24. PubMed ID: 9717833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor antigen-specific T-cell expansion is greatly facilitated by in vivo priming.
    Dang Y; Knutson KL; Goodell V; dela Rosa C; Salazar LG; Higgins D; Childs J; Disis ML
    Clin Cancer Res; 2007 Mar; 13(6):1883-91. PubMed ID: 17363545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparanase: a new metastasis-associated antigen recognized in breast cancer patients by spontaneously induced memory T lymphocytes.
    Sommerfeldt N; Beckhove P; Ge Y; Schütz F; Choi C; Bucur M; Domschke C; Sohn C; Schneeweis A; Rom J; Pollmann D; Leucht D; Vlodavsky I; Schirrmacher V
    Cancer Res; 2006 Aug; 66(15):7716-23. PubMed ID: 16885374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural T cell immunity against cancer.
    Nagorsen D; Scheibenbogen C; Marincola FM; Letsch A; Keilholz U
    Clin Cancer Res; 2003 Oct; 9(12):4296-303. PubMed ID: 14555498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of adjuvant hormone therapy and chemotherapy on the immune system analysed in the bone marrow of patients with breast cancer.
    Solomayer EF; Feuerer M; Bai L; Umansky V; Beckhove P; Meyberg GC; Bastert G; Schirrmacher V; Diel IJ
    Clin Cancer Res; 2003 Jan; 9(1):174-80. PubMed ID: 12538466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral cytokines and tumor cell biology determine spontaneous breast cancer-specific immune responses and their correlation to prognosis.
    Domschke C; Schuetz F; Ge Y; Seibel T; Falk C; Brors B; Vlodavsky I; Sommerfeldt N; Sinn HP; Kühnle MC; Schneeweiss A; Scharf A; Sohn C; Schirrmacher V; Moldenhauer G; Momburg F; Beckhove P
    Cancer Res; 2009 Nov; 69(21):8420-8. PubMed ID: 19843863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8 T-cell responses against cyclin B1 in breast cancer patients with tumors overexpressing p53.
    Sørensen RB; Andersen RS; Svane IM; Engell-Noerregaard L; Hadrup SR; Balslev E; Andersen MH; thor Straten P
    Clin Cancer Res; 2009 Mar; 15(5):1543-9. PubMed ID: 19223507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural T-cell response against MHC class I epitopes of epithelial cell adhesion molecule, her-2/neu, and carcinoembryonic antigen in patients with colorectal cancer.
    Nagorsen D; Keilholz U; Rivoltini L; Schmittel A; Letsch A; Asemissen AM; Berger G; Buhr HJ; Thiel E; Scheibenbogen C
    Cancer Res; 2000 Sep; 60(17):4850-4. PubMed ID: 10987297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell immunity to the folate receptor alpha is prevalent in women with breast or ovarian cancer.
    Knutson KL; Krco CJ; Erskine CL; Goodman K; Kelemen LE; Wettstein PJ; Low PS; Hartmann LC; Kalli KR
    J Clin Oncol; 2006 Sep; 24(26):4254-61. PubMed ID: 16908932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients.
    Bercovici N; Haicheur N; Massicard S; Vernel-Pauillac F; Adotevi O; Landais D; Gorin I; Robert C; Prince HM; Grob JJ; Leccia MT; Lesimple T; Wijdenes J; Bartholeyns J; Fridman WH; Salcedo M; Ferries E; Tartour E
    J Immunother; 2008 Jan; 31(1):101-12. PubMed ID: 18157017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in T-cell immunity toward tumor-associated antigens in colorectal cancer and breast cancer patients.
    Nagorsen D; Scheibenbogen C; Schaller G; Leigh B; Schmittel A; Letsch A; Thiel E; Keilholz U
    Int J Cancer; 2003 Jun; 105(2):221-5. PubMed ID: 12673683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced expression of surface tumor-associated antigens on human breast and colon tumor cells after recombinant human leukocyte alpha-interferon treatment.
    Greiner JW; Hand PH; Noguchi P; Fisher PB; Pestka S; Schlom J
    Cancer Res; 1984 Aug; 44(8):3208-14. PubMed ID: 6744259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HER-2 peptides p776 and F7, N-terminal-linked with Ii-Key tetramer (LRMK) help the proliferation of E75-TCR+ cells: The dependency of help on the side chains of LRMK-extended peptide pointed towards the T cell receptor.
    Li Y; Ishiyama S; Matsueda S; Tsuda N; Ioannides CG
    Oncol Rep; 2008 Jun; 19(6):1445-52. PubMed ID: 18497949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of prostate antigen-directed T cells in cancer patients compared to healthy age-matched individuals.
    Forsberg O; Carlsson B; Malmström PU; Ullenhag G; Tötterman TH; Essand M
    Prostate; 2009 Jan; 69(1):70-81. PubMed ID: 18814178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TAG family of cancer/testis antigens is widely expressed in a variety of malignancies and gives rise to HLA-A2-restricted epitopes.
    Adair SJ; Carr TM; Fink MJ; Slingluff CL; Hogan KT
    J Immunother; 2008 Jan; 31(1):7-17. PubMed ID: 18157007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.